trending Market Intelligence /marketintelligence/en/news-insights/trending/HQ747_L7B41jf1iZ_ZC9Og2 content esgSubNav
In This List

US FDA clears NuVasive's cervical cage system

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


US FDA clears NuVasive's cervical cage system

The U.S. FDA granted NuVasive Inc. clearance for its CoRoent small interbody system, indicated for intervertebral body fusion at multiple contiguous levels in the cervical spine.

The cervical cage is intended for the treatment of multilevel cervical disc degeneration in patients displaying cervical radiculopathy and myelopathy. The device provides stabilization of the spinal motion segment while fusion takes place.

The implants included in the clearance are CoRoent small, CoRoent small lordotic, CoRoent small lordotic plus, CoRoent small hyperlordotic and CoRoent small contoured.

The FDA approval is the first U.S. clearance for the use of a cervical cage at up to four contiguous levels.